These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 21595778)

  • 1. Safety and efficacy of self-expanding removable metal esophageal stents during neoadjuvant chemotherapy for resectable esophageal cancer.
    Pellen MG; Sabri S; Razack A; Gilani SQ; Jain PK
    Dis Esophagus; 2012 Jan; 25(1):48-53. PubMed ID: 21595778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placement of fully covered self-expandable metal stents in patients with locally advanced esophageal cancer before neoadjuvant therapy.
    Siddiqui AA; Sarkar A; Beltz S; Lewis J; Loren D; Kowalski T; Fang J; Hilden K; Adler DG
    Gastrointest Endosc; 2012 Jul; 76(1):44-51. PubMed ID: 22726465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Expanding Metal Stents Improve Swallowing and Maintain Nutrition During Neoadjuvant Therapy for Esophageal Cancer.
    Smith ZL; Gonzaga JE; Haasler GB; Gore EM; Dua KS
    Dig Dis Sci; 2017 Jun; 62(6):1647-1656. PubMed ID: 28391413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided?
    Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE
    Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
    Siddiqui AA; Glynn C; Loren D; Kowalski T
    Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy versus self-expanding metal stent as primary treatment of severe dysphagia from unresectable oesophageal or gastro-oesophageal junction cancer.
    Touchefeu Y; Archambeaud I; Landi B; Lièvre A; Lepère C; Rougier P; Mitry E
    Dig Liver Dis; 2014 Mar; 46(3):283-6. PubMed ID: 24268567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relief of dysphagia during neoadjuvant treatment for cancer of the esophagus or gastroesophageal junction.
    Sunde B; Ericson J; Kumagai K; Lundell L; Tsai JA; Lindblad M; Rouvelas I; Friesland S; Wang N; Nilsson M
    Dis Esophagus; 2016 Jul; 29(5):442-7. PubMed ID: 25809837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Placement of Polyflex stents in patients with locally advanced esophageal cancer is safe and improves dysphagia during neoadjuvant therapy.
    Adler DG; Fang J; Wong R; Wills J; Hilden K
    Gastrointest Endosc; 2009 Oct; 70(4):614-9. PubMed ID: 19539918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Results of Temporary Placement of Retrievable Expandable Metallic Stents during Preoperative Neoadjuvant Chemoradiotherapy in Patients with Resectable Esophageal Cancer.
    Park JH; Song HY; Shin JH; Kim JH; Kim YH; Kim SB; Kim JH
    J Vasc Interv Radiol; 2015 Jun; 26(6):883-8. PubMed ID: 25724088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective phase II evaluation of esophageal stenting for neoadjuvant therapy for esophageal cancer: optimal performance and surgical safety.
    Brown RE; Abbas AE; Ellis S; Williams S; Scoggins CR; McMasters KM; Martin RC
    J Am Coll Surg; 2011 Apr; 212(4):582-8; discussion 588-9. PubMed ID: 21463793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of palliative esophageal stenting for malignant dysphagia: a retrospective analysis.
    Burstow M; Kelly T; Panchani S; Khan IM; Meek D; Memon B; Memon MA
    Dis Esophagus; 2009; 22(6):519-25. PubMed ID: 19302213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy.
    Langer FB; Schoppmann SF; Prager G; Tomaselli F; Pluschnig U; Hejna M; Schmid R; Zacherl J
    Ann Surg Oncol; 2010 Feb; 17(2):470-5. PubMed ID: 19859771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma.
    Okamura A; Watanabe M; Mine S; Kurogochi T; Yamashita K; Hayami M; Imamura Y; Ogura M; Ichimura T; Takahari D; Chin K
    Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptable results after self-expanding metallic stent treatment for dysphagia in non-resectable oesophageal cancer.
    Bjerring OS; Pless T; Fristrup C; Mortensen MB
    Dan Med J; 2012 Jun; 59(6):A4459. PubMed ID: 22677249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
    Bower M; Jones W; Vessels B; Scoggins C; Martin R
    Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The palliation of dysphagia secondary to esophageal-cardial carcinoma with self-expandable metal prostheses. The authors' personal experience with 92 patients].
    De Palma GD; Sivero L; Galloro G; Siciliano S; Pigna F; Catanzano C
    Minerva Chir; 1999 Apr; 54(4):213-8. PubMed ID: 10380518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-expanding plastic stent removed after radiochemotherapy for advanced esophageal cancer.
    Laquière A; Grandval P; Heresbach D; Prat F; Arpurt JP; Bichard P; D'Halluin PN; Berthillier J; Boustière C; Laugier R
    Dis Esophagus; 2014; 27(2):176-81. PubMed ID: 23651038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis.
    Nabeya Y; Ochiai T; Matsubara H; Okazumi S; Shiratori T; Shuto K; Aoki T; Miyazaki S; Gunji Y; Uno T; Ito H; Shimada H
    Dis Esophagus; 2005; 18(6):388-97. PubMed ID: 16336610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of preoperative chemotherapy with docetaxel, cisplatin, and 5-fluorouracil followed by esophagectomy in patients with resectable node-positive esophageal cancer.
    Watanabe M; Baba Y; Yoshida N; Ishimoto T; Nagai Y; Iwatsuki M; Iwagami S; Baba H
    Ann Surg Oncol; 2014 Sep; 21(9):2838-44. PubMed ID: 24715216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.